Patients Discontinuing Weight-Loss Medications Regain Weight Far More Rapidly Than Dieters

A recent study indicates that individuals who come off new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who halt traditional diet and exercise plans.

Published data in a prominent medical journal shows that while obese people frequently drop substantial amounts of their total mass while on the medication, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.

"Users using such treatments need to be aware of the risk of quick rebound weight gain when the treatment ends," cautioned researcher Dr. Susan Jebb.

Such speed of regain suggests a reversion to starting mass in about a year and a half.

Analyzing Therapies

The research, which looked at 37 of trials involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with other pills.

The team point out that people who lose weight through lifestyle changes alone typically see a more gradual weight regain—approximately 0.1 kg a month—once they finish.

The Reason for the Quick Rebound

Nutrition scientists propose the way of the jabs is key to understanding the amplified weight return.

The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 levels far above than the body's typical production may cause the body to produce less of its own natural GLP-1, and could lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this GLP-1 'fix' means appetite is unsuppressed, making overeating a significant risk."

A Lifelong Issue?

Health authorities recommend the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

Many experts say that, given the likelihood of relapse, the therapy might need to be ongoing.

This opinion is supported by drug manufacturers, who say that the findings "highlight the long-term nature of obesity," akin to managing conditions like diabetes.

User Accounts

Users who have come off the medication report a sudden return of cravings.

"I experienced a trigger that goes on and you become starving," recalled an individual.

The struggle is exacerbated if users have not established sustainable lifestyle or habit changes during treatment.

Significant Use

Survey data suggest that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.

• Use is more common among females than males.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion access the drugs through private healthcare rather than public health services.

In conclusion, researchers caution that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on integrated lifestyle management.